Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Pediatric high-grade glioma (pHGG) is the leading cause of cancer death in children. Despite histologic similarities, it has recently become apparent that this disease is molecularly distinct from its adult counterpart. Specific hallmark oncogenic histone mutations within pediatric malignant gliomas...
Main Authors: | Maya S. Graham, Ingo K. Mellinghoff |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/19/7193 |
Similar Items
-
Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
by: Andrew Groves, et al.
Published: (2022-12-01) -
Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
by: Lucia De Martino, et al.
Published: (2023-07-01) -
Clinical Presentation, MRI findings and Molecular insights in Diffuse Intrinsic Pontine Gliomas (DIPGs): A Comprehensive Review.
by: Gustavo Novelino Simao
Published: (2023-09-01) -
New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
by: Davis P. Argersinger, et al.
Published: (2021-10-01) -
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas
by: Peter Raab, et al.
Published: (2022-03-01)